Showing results (51-60 of 99) with videos related to
Sort By:
Pageof 10
Pediatric Neurosurgery|April 5, 2001
Prognostic implications for gadolinium enhancement of the meninges in low-grade astrocytomas of childhoodM D Hurwitz, P C Burger, P T Goldthwaite, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2015
What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalationNicholas G Zaorsky, Joshua D Palmer, Mark D Hurwitz, et al.Critical Care Medicine|December 1, 1987
Transbronchial biopsy during mechanical ventilationP S Pincus, J M Kallenbach, M D Hurwitz, et al.Intensive Care Medicine|January 1, 1989
Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" coreC Feldman, J M Kallenbach, H Levy, et al.Urology|August 15, 2006
Radical prostatectomy for high-grade prostate cancerMark D Hurwitz, Delray Schultz, Jerome P Richie, et al.Cancer|April 27, 2012
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809Mark D Hurwitz, Susan Halabi, Laura Archer, et al.American Journal of Clinical Oncology|March 8, 2023
ACR-ARS Practice Parameter on Informed Consent Radiation OncologyMark D Hurwitz, Anupama Chundury, Chelain R Goodman, et al.International Journal of Radiation Oncology, Biology, Physics|June 23, 2000
Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapyM D Thomas, R Cormack, C M Tempany, et al.International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809Mark D Hurwitz, Susan Halabi, San-San Ou, et al.Cancer|October 2, 2010
Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153Mark D Hurwitz, Jorgen L Hansen, Savina Prokopios-Davos, et al.Pageof 10